News|Articles|June 1, 2002
- Pharmaceutical Technology-06-02-2002
- Volume 26
- Issue 6
Drug Shortages Reveal GMP Concerns
Author(s)Jill Wechsler
FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.
Advertisement
Articles in this issue
over 23 years ago
Excipient GMP Quality Standards: One is Enoughover 23 years ago
The IPEC-Americas Excipient Master File Guideover 23 years ago
Technology Advances Anticounterfeiting Optionsover 23 years ago
Calibration of Lyophilization Pressure Gaugesover 23 years ago
Outsourcing Outlookover 23 years ago
Optimizing Cross-Organizational Team Performance and Managementover 23 years ago
Screening for Counterfeit Drugs Using Near-Infrared Spectroscopyover 23 years ago
Building on Tradition: Integrating the Links of ExpertiseNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
4
New Targets for Clinical Trials in the European Union
5
